Search Results - "Pureur, Dimitri"

Evaluation of the interest to combine a CD4 Th1-inducer cancer vaccine derived from telomerase and atezolizumab plus bevacizumab in unresectable hepatocellular carcinoma: a randomized non-comparative phase II study (TERTIO - PRODIGE 82) by Vienot, Angélique, Jacquin, Marion, Rebucci-Peixoto, Magali, Pureur, Dimitri, Ghiringhelli, François, Assenat, Eric, Hammel, Pascal, Rosmorduc, Olivier, Stouvenot, Morgane, Allaire, Manon, Bouattour, Mohamed, Regnault, Hélène, Fratte, Serge, Raymond, Eric, Soularue, Emilie, Husson-Wetzel, Stéphanie, Di Martino, Vincent, Muller, Allison, Clairet, Anne-Laure, Fagnoni-Legat, Christine, Adotevi, Olivier, Meurisse, Aurélia, Vernerey, Dewi, Borg, Christophe

“…Several cancer immunotherapies that target the PD-L1/PD-1 pathway show promising clinical activity in patients with hepatocellular carcinoma (HCC). However,…”
Get full text

Transjugular Intrahepatic Portosystemic Shunt is effective to treat portal hypertension due to sinusoidal obstructive syndrome by Hountondji, Lina, Pureur, Dimitri, Chabannes, Melchior, Felix, Sophie, Thévenot, Thierry

“…Transjugular Intrahepatic Portosystemic Shunt (TIPS) is an established procedure for the complications of portal hypertension, such as variceal bleeding,…”
Get full text

Nouvelles AMM : durvalumab et tremelimumab en première ligne dans le carcinome hépatocellulaire avancé by Pureur, Dimitri, Edeline, Julien

Get full text

SAT-306 Time to use the right classification to predict the severity of checkpoint inhibitor-induced liver injury by Hountondji, Lina, Faure, Stéphanie, Palassin, Pascale, Viel, PhilineWitkowski Durand, Dupuy, Marie, Larrey, Dominique, Lamoureux, Anouck, Pureur, Dimitri, Coustal, Cyril, Lesage, Candice, Assenat, Eric, Riviere, Benjamin, Faillie, Jean-Luc, Quantin, Xavier, Maria, Alexandre, Pageaux, Georges-Philippe, Meunier, Lucy

Get full text

Time to use the right classification to predict the severity of checkpoint inhibitor-induced liver injury, as assessed for causality using the updated RUCAM by Hountondji, Lina, Faure, Stéphanie, Palassin, Pascale, Viel, Philine Witkowski Durand, Dupuy, Marie, Larrey, Dominique, Lamoureux, Anouck, Coustal, Cyrille, Pureur, Dimitri, Lesage, Candice, Assenat, Éric, Rivière, Benjamin, Faillie, Jean-Luc, Quantin, Xavier, Pageaux, Georges-Philippe, Maria, Alexandre Thibault Jacques, Meunier, Lucy

“…While immune checkpoint inhibitors (ICIs) are revolutionising cancer therapy, checkpoint inhibitor-induced liver injury is a significant immune-related side…”
Get full text

Pembrolizumab en première ligne thérapeutique dans les cancers colorectaux métastatiques présentant une instabilité microsatellitaire élevée MSI by Pureur, Dimitri, Rodrigues, Manuel, Turpin, Anthony

Get full text

Transjugular Intrahepatic Portosystemic Shunt is effective to treat portal hypertension due to sinusoidal obstructive syndrome by Hountondji, Lina, Pureur, Dimitri, Chabannes, Melchior, Felix, Sophie, Thévenot, Thierry

Get full text